Salvatore Privitera, VP Engineering & Product Development at AtriCure, Inc. (ATRC), sold 10,000 shares at $3.25 ($30K) on 2009-06-08, disclosed to the SEC on 2009-06-08.
Open-market sale of $30k ATRC by VP Engineering & Product Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.75 | 5,000 | $14K | 45.8% |
| 2 | $3.25 | 5,000 | $16K | 54.2% |
| Total | $3.00 avg | 10,000 | $30K | 100% |
| Filing → |
| ATRC | BUY | 2024-05-31 | $111K | — | Filing → |
| ATRC | SELL | 2021-08-03 | $749K | — | Filing → |
| ATRC | SELL | 2021-07-30 | $660K | — | Filing → |